CN Stock MarketDetailed Quotes

688488 Jiangsu Aidea Pharmaceutical

Watchlist
  • 10.17
  • +0.16+1.60%
Market Closed Nov 12 15:00 CST
4.28BMarket Cap-41008P/E (TTM)

Jiangsu Aidea Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Aidea Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
117.81M
--
+87.54%
Net Income
--
-16.29M
--
+28.74%
Analyst Rating
Strong Buy

Nov 12, 2024

Jiangsu Aidea Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 834.865M --
-- 2024/FY -- / 508.615M --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 834.865M--
--2024/FY-- / 508.615M--
--------
--------
--------

Unlock Free Earnings Estimates

Jiangsu Aidea Pharmaceutical Earnings Reports

  • Eddy Pharmaceuticals: Eddy Pharmaceuticals Third Quarter 2024 Report

    Oct 31 00:00

  • Eddy Pharmaceuticals 2024 Third Quarter Report

    Oct 31 00:00

  • Jiangsu Aidea Pharmaceutical 2024 Interim Report

    Aug 23 00:00

  • Summary of Aidea Pharmaceutical's semi-annual report for 2024.

    Aug 23 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Strong Buy

    • Strong Buy

      77.78%

    • Buy

      22.22%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data